Navigation Links
Surprising finding from smoke inhalation study
Date:4/1/2011

MAYWOOD, Ill. -- An award-winning Loyola University Health System study includes some unexpected findings about the immune systems of smoke-inhalation patients.

Contrary to expectations, patients who died from their injuries had lower inflammatory responses in their lungs than patients who survived.

"Perhaps a better understanding of this early pulmonary immune dysfunction will allow for therapies that further improve outcomes in burn care," researchers reported.

Results were released at the 43rd annual meeting of the American Burn Association. The project won the 2011 Carl A. Moyer Resident Award for the best study submitted by a resident physician.

First author of the study is Christopher S. Davis, MD, a general surgery resident at Loyola University Hospital. Corresponding author is Elizabeth J. Kovacs, PhD, associate director of the Burn & Shock Trauma Institute at Loyola University Chicago Stritch School of Medicine.

Researchers followed 60 burn patients at the Loyola University Hospital Burn Center. The severity of inhalation injury was categorized into one of five grades (0, 1, 2, 3, and 4), with zero being the absence of visible injury.

As expected, patients with the worst combined burn-and-smoke-inhalation injuries required more time on the ventilator, in the intensive care unit and in the hospital. They also were more likely to die, although this finding fell just short of being statistically significant.

Also according to expectations, patients who died were older and had larger injuries than patients who survived.

But the immune system findings were unexpected. Researchers measured concentrations of 28 immune system modulators in fluid collected from the lungs of patients within 14 hours of burn and smoke-inhalation injuries.

These modulators are proteins produced by leukocytes (white blood cells) and other cells, including those that line the airway. Some of the modulators recruit leukocytes to areas of tissue dam
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds surprising gender differences related to sexual harassment
2. Pancreatic Cancer Surprisingly Slow to Arise: Study
3. Surprising find may yield new avenue of treatment for painful herniated discs
4. Anger Spurs Surprising Changes in the Body
5. Stanford/Packard study finds surprising disparity in where chronically ill kids hospitalized
6. Cosmetic Surgery Error in New York Strikes Medical Malpractice Lawyers as Unsurprising
7. Finding of long-sought drug target structure may expedite drug discovery
8. New findings on drug tolerance in TB suggest ideas for shorter cures
9. Latest findings of Dartmouth HIV/AIDS study could turn treatment on its head
10. Research provides new findings on drug delivery with nanoparticles
11. SMFM highlights significance of spina bifida research findings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Regents Health Resources, a consulting firm ... health care industry veteran Daryl Demonbreun and former St. ... the company’s ambitious plans to grow into a full-service ... moving along at a steady pace for nearly 20 ... notch,” says Bob Maier, founder and chief executive officer ...
(Date:7/29/2014)... Test instruments after processing to assure ... where it matters most – on the surgical ... premium domestic appliances, introduces ProCare Protein Check, a ... cleaned. The ProCare liquid is applied directly to ... After 3 minutes, users visually determine the presence ...
(Date:7/29/2014)... rates rise in association with extremely hot weather. The ... 2003, for example, resulted in about 22,000 extra deaths. ... at the Institute of Epidemiology II at the Helmholtz ... the number of deaths caused by cardiovascular disease in ... temperatures in the study. , "Our findings confirm the ...
(Date:7/29/2014)... Healthcare staffing agency Medical Solutions ... Tomorrow Scholarship Competition winners:, ,     Alonso ...     Racheal D., Freshman, Cerritos College in Norwalk, ... College in Houston, TX , Each ... hosts the Nurses of Tomorrow Scholarship competition as ...
(Date:7/29/2014)... 2014 Gummy smile surgeon , Dr. ... gums treatments that can enhance and perfect gummy smiles and ... that displays the teeth to their best advantage. Some smiles ... have gums that are dark or discolored. Patients with these ... about their smiles or experience a high level of smile ...
Breaking Medicine News(10 mins):Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:ProCare Protein Check Tests Surgical Instruments to Verify Effective Cleaning 2Health News:Mortality rates increase due to extreme heat and cold 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:Gummy Smile Surgeon, Dr. Alex Farnoosh, Now Offers Procedures to Improve Gummy Smiles and Dark Gums 2
... ... Stroke and High Resolution, WATERTOWN, Mass., Sept. ... deformable mirror (DM),products for adaptive optics (AO) systems, today announced ... of the most innovative products,of 2007. In their annual Micro/Nano ...
... Challenge and AstraZeneca Join Forces to Promote Healthy ... Eating and Physical Activity, ... a new educational campaign will teach children ages,6-12 healthy habits both ... and AstraZeneca, "Habits for Health" will provide,250 schools, as well as ...
... N.Y., Sept. 10 Physicians and patients,of ... benefit from an,enhanced partnership between Physicians Practice ... more than 7,000 physicians in Brooklyn,and Staten ... thereby,improving patient care. (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/NETU093LOGO ...
... RELEASE , PCBs may threaten killer whale populations ... Orcas or killer whales may continue to suffer the ... next 30 60 years, despite 1970s-era regulations that ... in Canada report. Their study, which calls for better ...
... Just 13% of ,positive, phase II studies go forward despite ... than one in eight phase II cancer clinical trials with ... that,s needed to bring a new therapy to patients, a ... conducting the phase II effort knew beforehand that, due to ...
... Longstanding Tradition of Innovation in ... Leading Technology Provider, SILVER SPRING, Md. and ... the Center for Medical Simulation (CMS) today,announced that ... for the facility,s already cutting edge simulation programs.,B-Line ...
Cached Medicine News:Health News:Boston Micromachines Multi-DM Named One of the Year's Most Innovative Products 2Health News:Boston Micromachines Multi-DM Named One of the Year's Most Innovative Products 3Health News:Back-to-School Campaign Motivates Children and Parents to Embrace 'Habits for Health' 2Health News:Back-to-School Campaign Motivates Children and Parents to Embrace 'Habits for Health' 3Health News:Back-to-School Campaign Motivates Children and Parents to Embrace 'Habits for Health' 4Health News:Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors 2Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 2Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 3Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 4Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 5Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 6Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 7Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 8Health News:American Chemical Society's Weekly Presspac -- Sept. 5, 2007 9Health News:Study Questions Dead-End Cancer Clinical Trials 2Health News:Study Questions Dead-End Cancer Clinical Trials 3Health News:Study Questions Dead-End Cancer Clinical Trials 4Health News:Study Questions Dead-End Cancer Clinical Trials 5Health News:B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership 2Health News:B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership 3
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
(Date:7/28/2014)... STAAR Surgical Company (NASDAQ: STAA ... lenses and delivery systems for the eye has rescheduled ... call with investors to July 31, 2014 at 5:00 ... the release date and conference call to enable senior ... Watanabe , President of STAAR Japan, who passed away ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... , SAN DIEGO , Jan. 20, 2010 ... Quarterly Update Conference Call for the fourth quarter and full year 2009 ... / 2:00 p.m. PT . Daniel M. Bradbury , Amylin,s president ... post-market, Amylin will release financial results for the fourth quarter and year ...
... , PLEASANTON, Calif. , ... ), a world leader in device-based mechanical circulatory support therapies ... it has received FDA approval of its PMA (Pre-Market Approval) ... Ventricular Assist System) for Destination Therapy (DT).   , With ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Year-End Financial Results 2Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 2Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 3Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 4Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 5Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy 6
... Used to dilate the lower ... to assess possible submucosal tunneling. ... topical anesthetic in the ureter. ... by, or dislodgment of a ...
Used for drainage and retrograde pyelogram. The spiral tip aids in negotiation of a tortuous or partially obstructed ureter. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for the injection of contrast ... The dual lumen design eliminates the need ... designed to promote atraumatic passage into and ... layer of hydrophilic polymer that when activated, ...
Used for drainage and retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: